ArticleMovement disorders clinical practice2025

Discontinuation of the Clozapine Risk Evaluation and Mitigation Strategy and Implications in Movement Disorders.

Charles Palmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.